The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study of niraparib plus pembrolizumab in patients with triple-negative breast cancer or recurrent ovarian cancer (KEYNOTE-162).
 
Panagiotis Konstantinopoulos
Consulting or Advisory Role - Vertex
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Amgen (Inst); AstraZeneca; Genentech/Roche; Immunogen
Travel, Accommodations, Expenses - Amgen; AstraZeneca
 
Jasgit C. Sachdev
Honoraria - Celgene
Consulting or Advisory Role - Celgene
 
Monica M. Mita
No Relationships to Disclose
 
Shaveta Vinayak
No Relationships to Disclose
 
Shelly Marie Seward
Speakers' Bureau - AstraZeneca; Genentech
 
Vassiliki Karantza
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Gursel Aktan
Employment - GlaxoSmithKline; Merck Sharp & Dohme
Stock and Other Ownership Interests - GlaxoSmithKline; Merck Sharp & Dohme
 
Andrew Ferguson
Employment - Tesaro
Stock and Other Ownership Interests - Tesaro
 
Dmitri Bobilev
Employment - Tesaro
Stock and Other Ownership Interests - Tesaro
Travel, Accommodations, Expenses - Tesaro
 
Ursula A. Matulonis
Consulting or Advisory Role - AstraZeneca; Genentech; Immunogen; Merck KGaA; Tesaro